Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Imler GH"'
Autor:
Rahman MT; Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States., Guan D; Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States., Chaminda Lakmal HH; Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States., Decker AM; Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States., Imler GH; Center for Biomolecular Science and Engineering, Naval Research Laboratory, Code 6920, Washington, District of Columbia 20375, United States., Kerr AT; Center for Biomolecular Science and Engineering, Naval Research Laboratory, Code 6920, Washington, District of Columbia 20375, United States., Harris DL; Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States., Jin C; Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States.
Publikováno v:
ACS chemical neuroscience [ACS Chem Neurosci] 2024 Jan 03; Vol. 15 (1), pp. 169-192. Date of Electronic Publication: 2023 Dec 12.
Autor:
Das M; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, 9800 Medical Center Drive, Bethesda, MD 20892, USA., Ward GW; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, 9800 Medical Center Drive, Bethesda, MD 20892, USA., Sulima A; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, 9800 Medical Center Drive, Bethesda, MD 20892, USA., Luo D; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 S. Limestone Street, Lexington, KY 40536, USA., Prisinzano TE; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 S. Limestone Street, Lexington, KY 40536, USA., Imler GH; Center for Biomolecular Science and Engineering, Naval Research Laboratory, Washington, DC 20375, USA., Kerr AT; Center for Biomolecular Science and Engineering, Naval Research Laboratory, Washington, DC 20375, USA., Jacobson AE; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, 9800 Medical Center Drive, Bethesda, MD 20892, USA., Rice KC; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, 9800 Medical Center Drive, Bethesda, MD 20892, USA.
Publikováno v:
Molecules (Basel, Switzerland) [Molecules] 2023 Nov 22; Vol. 28 (23). Date of Electronic Publication: 2023 Nov 22.
Autor:
Cleveland AH; High Explosive Science and Technology, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States., Davis JV; High Explosive Science and Technology, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States., Imler GH; U.S. Naval Research Laboratory, Washington, D.C.20375, United States., Byrd EFC; U.S. Army Research Laboratory, Adelphi, Maryland 20783, United States., Snyder CJ; High Explosive Science and Technology, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States., Chavez DE; High Explosive Science and Technology, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States., Parrish DA; U.S. Naval Research Laboratory, Washington, D.C.20375, United States.
Publikováno v:
The Journal of organic chemistry [J Org Chem] 2023 Oct 20; Vol. 88 (20), pp. 14404-14412. Date of Electronic Publication: 2023 Oct 11.
Autor:
Froimowitz M; 90 Eastbourne Road, Newton Centre, Massachusetts 02459, United States., Taboada R; Massachusetts College of Pharmacy and Health Sciences, 179 Longwood Avenue, Boston, Massachusetts 02115, United States., Poulos ZJ; Massachusetts College of Pharmacy and Health Sciences, 179 Longwood Avenue, Boston, Massachusetts 02115, United States., Rainone DJ; Massachusetts College of Pharmacy and Health Sciences, 179 Longwood Avenue, Boston, Massachusetts 02115, United States., Imler GH; Naval Research Laboratory, Code 6930, 4555 Overlook Ave., SW, Washington D.C., 20375I, United States., Gardner EL; Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, 251 Bayview Blvd, Baltimore, Maryland 21224, United States., Kelley CJ; Massachusetts College of Pharmacy and Health Sciences, 179 Longwood Avenue, Boston, Massachusetts 02115, United States.
Publikováno v:
ACS omega [ACS Omega] 2023 Sep 18; Vol. 8 (39), pp. 35738-35745. Date of Electronic Publication: 2023 Sep 18 (Print Publication: 2023).
Autor:
Lutz JA; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, 9800 Medical Center Drive, Bethesda, MD 20892-3373, USA., Sulima A; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, 9800 Medical Center Drive, Bethesda, MD 20892-3373, USA., Gutman ES; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, 9800 Medical Center Drive, Bethesda, MD 20892-3373, USA., Bow EW; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, 9800 Medical Center Drive, Bethesda, MD 20892-3373, USA., Luo D; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 S. Limestone Street, Lexington, KY 40536, USA., Kaska S; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 S. Limestone Street, Lexington, KY 40536, USA., Prisinzano TE; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 S. Limestone Street, Lexington, KY 40536, USA., Paronis CA; McLean Hospital/Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA., Bergman J; McLean Hospital/Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA., Imler GH; Center for Biomolecular Science and Engineering, Naval Research Laboratory, Washington, DC 20375-0001, USA., Kerr AT; Center for Biomolecular Science and Engineering, Naval Research Laboratory, Washington, DC 20375-0001, USA., Jacobson AE; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, 9800 Medical Center Drive, Bethesda, MD 20892-3373, USA., Rice KC; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, 9800 Medical Center Drive, Bethesda, MD 20892-3373, USA.
Publikováno v:
Molecules (Basel, Switzerland) [Molecules] 2023 Jun 15; Vol. 28 (12). Date of Electronic Publication: 2023 Jun 15.
Autor:
Li F; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, Rockville, MD 20852, USA., Kopajtic TA; Psychobiology Section, Molecular Neuropsychiatry Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Katz JL; Psychobiology Section, Molecular Neuropsychiatry Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Luo D; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA., Prisinzano TE; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA., Imler GH; Center for Biomolecular Science and Engineering, Naval Research Laboratory, Washington, DC 20375, USA., Deschamps JR; Center for Biomolecular Science and Engineering, Naval Research Laboratory, Washington, DC 20375, USA., Jacobson AE; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, Rockville, MD 20852, USA., Rice KC; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, Rockville, MD 20852, USA.
Publikováno v:
Molecules (Basel, Switzerland) [Molecules] 2022 Dec 12; Vol. 27 (24). Date of Electronic Publication: 2022 Dec 12.
Autor:
Brandt AL; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada., Garai S; Department of Pharmaceutical Sciences, Bouvé College of Health Sciences, Boston, MA, United States., Zagzoog A; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada., Hurst DP; Center for Drug Discovery, University of North Carolina Greensboro, Greensboro, NC, United States., Stevenson LA; School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom., Pertwee RG; School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom., Imler GH; Centre for Biomolecular Science and Engineering, Naval Research Laboratory, Washington, DC, United States., Reggio PH; Center for Drug Discovery, University of North Carolina Greensboro, Greensboro, NC, United States., Thakur GA; Department of Pharmaceutical Sciences, Bouvé College of Health Sciences, Boston, MA, United States., Laprairie RB; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada.; Department of Pharmacology, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2022 Oct 25; Vol. 13, pp. 919605. Date of Electronic Publication: 2022 Oct 25 (Print Publication: 2022).
Autor:
Chavez DE; Q Division, Los Alamos National Laboratory Los Alamos 87545 NM USA vkuehl@lanl.gov., Tappan BC; Q Division, Los Alamos National Laboratory Los Alamos 87545 NM USA vkuehl@lanl.gov., Kuehl VA; Q Division, Los Alamos National Laboratory Los Alamos 87545 NM USA vkuehl@lanl.gov., Schmalzer AM; Q Division, Los Alamos National Laboratory Los Alamos 87545 NM USA vkuehl@lanl.gov., Leonard PW; Q Division, Los Alamos National Laboratory Los Alamos 87545 NM USA vkuehl@lanl.gov., Wu R; Q Division, Los Alamos National Laboratory Los Alamos 87545 NM USA vkuehl@lanl.gov., Imler GH; Naval Research Laboratory DC 20735 Washington USA., Parrish DA; Naval Research Laboratory DC 20735 Washington USA.
Publikováno v:
RSC advances [RSC Adv] 2022 Oct 06; Vol. 12 (44), pp. 28490-28493. Date of Electronic Publication: 2022 Oct 06 (Print Publication: 2022).
Autor:
Chambers DR; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, 9800 Medical Center Drive, Bethesda, MD 20892, USA., Sulima A; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, 9800 Medical Center Drive, Bethesda, MD 20892, USA., Luo D; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 S. Limestone Street, Lexington, KY 40536, USA., Prisinzano TE; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 S. Limestone Street, Lexington, KY 40536, USA., Goldberg A; Computational Chemistry and Molecular Biophysics Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, 333 Cassell Drive, Baltimore, MD 21224, USA., Xie B; Computational Chemistry and Molecular Biophysics Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, 333 Cassell Drive, Baltimore, MD 21224, USA., Shi L; Computational Chemistry and Molecular Biophysics Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, 333 Cassell Drive, Baltimore, MD 21224, USA., Paronis CA; McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA., Bergman J; McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA., Nassehi N; Department of Pharmacology and Toxicology, Virginia Commonwealth University, 1112 East Clay Street, Richmond, VA 23298, USA., Selley DE; Department of Pharmacology and Toxicology, Virginia Commonwealth University, 1112 East Clay Street, Richmond, VA 23298, USA., Imler GH; Naval Research Laboratory, Center for Biomolecular Science and Engineering, Washington, DC 20375, USA., Jacobson AE; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, 9800 Medical Center Drive, Bethesda, MD 20892, USA., Rice KC; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, 9800 Medical Center Drive, Bethesda, MD 20892, USA.
Publikováno v:
Molecules (Basel, Switzerland) [Molecules] 2022 Sep 30; Vol. 27 (19). Date of Electronic Publication: 2022 Sep 30.
Autor:
Mian MY; Department of Chemistry and Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53211, United States., Divović B; Department of Pharmacology, Faculty of Pharmacy, University of Belgrade, Belgrade 11000, Serbia., Sharmin D; Department of Chemistry and Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53211, United States., Pandey KP; Department of Chemistry and Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53211, United States., Golani LK; Department of Chemistry and Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53211, United States., Tiruveedhula VVNPB; Department of Chemistry and Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53211, United States., Cerne R; Laboratory of Antiepileptic Drug Discovery, St. Vincent's Hospital, Indianapolis, Indiana 46260, United States.; Department of Anatomy and Cell Biology, Indiana University/Purdue University, Indianapolis, Indiana 46202, United States.; Faculty of Medicine, University of Ljubljana, Zaloška cesta 4, 1000 Ljubljana, Slovenia.; RespireRx Pharmaceuticals Inc., Glen Rock, New Jersey 07452, United States., Smith JL; Laboratory of Antiepileptic Drug Discovery, St. Vincent's Hospital, Indianapolis, Indiana 46260, United States., Ping X; Department of Anatomy and Cell Biology, Indiana University/Purdue University, Indianapolis, Indiana 46202, United States., Jin X; Department of Anatomy and Cell Biology, Indiana University/Purdue University, Indianapolis, Indiana 46202, United States., Imler GH; Naval Research Laboratory, Washington, District of Columbia 20375, United States., Deschamps JR; Naval Research Laboratory, Washington, District of Columbia 20375, United States., Lippa A; RespireRx Pharmaceuticals Inc., Glen Rock, New Jersey 07452, United States., Cook JM; Department of Chemistry and Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53211, United States.; RespireRx Pharmaceuticals Inc., Glen Rock, New Jersey 07452, United States., Savić MM; Department of Pharmacology, Faculty of Pharmacy, University of Belgrade, Belgrade 11000, Serbia., Rowlett J; Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi 39216, United States., Witkin JM; Department of Chemistry and Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53211, United States.; Laboratory of Antiepileptic Drug Discovery, St. Vincent's Hospital, Indianapolis, Indiana 46260, United States.; RespireRx Pharmaceuticals Inc., Glen Rock, New Jersey 07452, United States.
Publikováno v:
ACS omega [ACS Omega] 2022 Jul 27; Vol. 7 (31), pp. 27550-27559. Date of Electronic Publication: 2022 Jul 27 (Print Publication: 2022).